Sep 13, 2017
Applied Clinical Trials
Due to a shifting landscape because of faster drug approvals, this article offers strategies for sponsors to design clinical trials.
Mar 27, 2017
In the search for more effective treatments and cures, there are challenges that sponsors and CROs must confront when conducting IMID clinical trials.
Feb 23, 2017
Drug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.
Sep 28, 2016
While block randomization has been shown to be a more frequently used form of trial randomization design, the use of dynamic randomization has been shown to have optimal treatment group balancing results.
Sep 12, 2016
Immunotherapy drugs have led to successes in the oncology space as the list of cancer survivors continues to grow. However, more work must be done to ensure that all patients who can benefit from these life-saving drugs receive them.
Jun 20, 2016
Progress and innovation within oncology has accelerated to a paradigm that includes immunotherapy and bio-genomics. Collaborative approaches in the future will continue to transform treatments in hopes of improving patient quality of life.
Feb 22, 2016
With significant technology advances in ECG recording through the years, the need to expand on traditional monitoring baselines—and include new variables such as time when designing clinical trial protocols—is important.
Jan 21, 2016
This article explores the many challenges to creating a pharmaceutical development program for the treatment of a rare disease.
Jan 21, 2016
Applied Clinical Trials
By Applied Clinical Trials Editors
The EU-AIMS Longitudinal European Autism Project (LEAP) is combining genetic testing, neuroimaging, cognitive testing and clinical assessments to identify biological risk markers associated with subtypes of autism.
Sep 08, 2015
Applied Clinical Trials
In recent years, the United States has witnessed significant progress in the fight against cancer, with survival rates increasing from 49% in the mid-1970s to 68% today.
native1_300x100
lorem ipsum